DGS Capital Management LLC Acquires 408 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

DGS Capital Management LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 47.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 1,275 shares of the medical equipment provider’s stock after buying an additional 408 shares during the quarter. DGS Capital Management LLC’s holdings in Intuitive Surgical were worth $509,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ISRG. Baystate Wealth Management LLC increased its position in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the period. MCF Advisors LLC raised its stake in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares in the last quarter. Able Wealth Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth about $28,000. Atticus Wealth Management LLC boosted its position in Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 41 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the sale, the director now directly owns 25,319 shares in the company, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,956 shares of company stock worth $6,927,011. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.6 %

Shares of NASDAQ:ISRG opened at $445.11 on Friday. The stock has a 50 day moving average of $400.81 and a 200 day moving average of $381.34. The company has a market cap of $157.88 billion, a PE ratio of 80.34, a price-to-earnings-growth ratio of 5.72 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $445.79.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company’s revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.00 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on ISRG shares. Piper Sandler lifted their price target on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday, April 19th. BTIG Research boosted their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. Citigroup boosted their price target on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Finally, StockNews.com downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $403.67.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.